{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:12:38Z","timestamp":1790773958936,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incomplete understanding of aberrant neovascularization, which contributes to osteoarthritis suggests that additional modulators have yet to be identified. Our objective was to identify the role of Leucine-rich-alpha-2-glycoprotein1 (LRG1), a new regulator of pathogenic angiogenesis, in osteoarthritis progression and to develop effective treatment strategies. In this study, immunohistochemistry showed that LRG1 was increased in the subchondral bone and articular cartilage in anterior cruciate ligament transection (ACLT) mice. Further studies were focused on the role of LRG1 in osteoarthritis. Results showed that LRG1 promoted angiogenesis and mesenchymal stem cells (MSC) migration, which contribute to aberrant bone formation in the subchondral bone. Moreover, tumor necrosis factor-<jats:italic>\u03b1<\/jats:italic> (TNF-<jats:italic>\u03b1<\/jats:italic>), not interleukin-1<jats:italic>\u03b2<\/jats:italic> (IL-1<jats:italic>\u03b2<\/jats:italic>), IL-6 or IL-17, induced the LRG1 expression in human umbilical vein endothelial cells and this effect was inhibited by p38 mitogen-activated protein kinase or NF-<jats:italic>\u03ba<\/jats:italic>B inhibitor. Notably, inhibition of TNF-<jats:italic>\u03b1<\/jats:italic> and LRG1 activity by Lenalidomide, an inhibitor of TNF-<jats:italic>\u03b1<\/jats:italic> production, in ACLT mice attenuated degeneration of osteoarthritis articular cartilage. This study shows that TNF-<jats:italic>\u03b1<\/jats:italic> is the predominant proinflammatory cytokine that induces the secretion of LRG1. LRG1 contributes to angiogenesis-coupled <jats:italic>de novo<\/jats:italic> bone formation by increasing angiogenesis and recruiting MSCs in the subchondral bone of osteoarthritis joints. Inhibition of TNF-<jats:italic>\u03b1<\/jats:italic> and LRG1 by Lenalidomide could be a potential therapeutic approach.<\/jats:p>","DOI":"10.1038\/cddis.2017.129","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T12:49:21Z","timestamp":1490878161000},"page":"e2715-e2715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["TNF-\u03b1-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis"],"prefix":"10.1038","volume":"8","author":[{"given":"Yiyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"BFcddis2017129_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/art.21562","volume":"54","author":"JM Hootman","year":"2006","unstructured":"Hootman JM, Helmick CG . Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54: 226\u2013229.","journal-title":"Arthritis Rheum"},{"key":"BFcddis2017129_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H . Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7: 33\u201342.","journal-title":"Nat Rev Rheumatol"},{"key":"BFcddis2017129_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm.3143","volume":"19","author":"G Zhen","year":"2013","unstructured":"Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013; 19: 704\u2013712.","journal-title":"Nat Med"},{"key":"BFcddis2017129_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2012.80","volume":"8","author":"PI Mapp","year":"2012","unstructured":"Mapp PI, Walsh DA . Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012; 8: 390\u2013398.","journal-title":"Nat Rev Rheumatol"},{"key":"BFcddis2017129_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","volume":"9","author":"I Andia","year":"2013","unstructured":"Andia I, Maffulli N . Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 2013; 9: 721\u2013730.","journal-title":"Nat Rev Rheumatol"},{"key":"BFcddis2017129_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bone.2011.10.010","volume":"51","author":"S Suri","year":"2012","unstructured":"Suri S, Walsh DA . Osteochondral alterations in osteoarthritis. Bone 2012; 51: 204\u2013211.","journal-title":"Bone"},{"key":"BFcddis2017129_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.joca.2014.05.023","volume":"22","author":"XL Yuan","year":"2014","unstructured":"Yuan XL, Meng HY, Wang YC, Peng J, Guo QY, Wang AY et al. Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthritis Cartilage 2014; 22: 1077\u20131089.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2017129_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/ard.62.2.100","volume":"62","author":"EM Gravallese","year":"2003","unstructured":"Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A et al. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis 2003; 62: 100\u2013107.","journal-title":"Ann Rheum Dis"},{"key":"BFcddis2017129_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00167-010-1054-z","volume":"18","author":"H Madry","year":"2010","unstructured":"Madry H, van Dijk CN, Mueller-Gerbl M . The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc 2010; 18: 419\u2013433.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"BFcddis2017129_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrrheum.2010.197","volume":"7","author":"RJ Lories","year":"2011","unstructured":"Lories RJ, Luyten FP . The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 2011; 7: 43\u201349.","journal-title":"Nat Rev Rheumatol"},{"key":"BFcddis2017129_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature12345","volume":"499","author":"X Wang","year":"2013","unstructured":"Wang X, Abraham S, McKenzie JA, Jeffs N, Swire M, Tripathi VB et al. LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling. Nature 2013; 499: 306\u2013311.","journal-title":"Nature"},{"key":"BFcddis2017129_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13046-016-0306-2","volume":"35","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zhu L, Fang J, Ge Z, Li X . LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1alpha activation. J Exp Clin Cancer Res 2016; 35: 29.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFcddis2017129_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.acthis.2015.05.001","volume":"117","author":"D Zhong","year":"2015","unstructured":"Zhong D, He G, Zhao S, Li J, Lang Y, Ye W et al. LRG1 modulates invasion and migration of glioma cell lines through TGF-beta signaling pathway. Acta Histochem 2015; 117: 551\u2013558.","journal-title":"Acta Histochem"},{"key":"BFcddis2017129_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","volume":"10","author":"A Marrelli","year":"2011","unstructured":"Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R et al. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev 2011; 10: 595\u2013598.","journal-title":"Autoimmun Rev"},{"key":"BFcddis2017129_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0960-894X(99)00250-4","volume":"9","author":"GW Muller","year":"1999","unstructured":"Muller GW, Chen R, Huang SY, Corral LG, Wong LM, Patterson RT et al. Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett 1999; 9: 1625\u20131630.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcddis2017129_CR16","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F et al. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 2002; 100: 3063\u20133067.","journal-title":"Blood"},{"key":"BFcddis2017129_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood.V98.1.210","volume":"98","author":"FE Davies","year":"2001","unstructured":"Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 2001; 98: 210\u2013216.","journal-title":"Blood"},{"key":"BFcddis2017129_CR18","doi-asserted-by":"publisher","first-page":"e64354","DOI":"10.1371\/journal.pone.0064354","volume":"8","author":"B Yang","year":"2013","unstructured":"Yang B, Yu RL, Chi XH, Lu XC . Lenalidomide treatment for multiple myeloma: systematic review and meta-analysis of randomized controlled trials. PLoS ONE 2013; 8: e64354.","journal-title":"PLoS ONE"},{"key":"BFcddis2017129_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00280-016-3068-9","volume":"78","author":"F Bridoux","year":"2016","unstructured":"Bridoux F, Chen N, Moreau S, Arnulf B, Moumas E, Abraham J et al. Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment. Cancer Chemother Pharmacol 2016; 78: 173\u2013182.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcddis2017129_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12967-016-0872-2","volume":"14","author":"V Leuci","year":"2016","unstructured":"Leuci V, Maione F, Rotolo R, Giraudo E, Sassi F, Migliardi G et al. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. J Transl Med 2016; 14: 119.","journal-title":"J Transl Med"},{"key":"BFcddis2017129_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829\u2013834.","journal-title":"Nature"},{"key":"BFcddis2017129_CR22","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s00018-004-4144-6","volume":"61","author":"C Wiese","year":"2004","unstructured":"Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y et al. Nestin expression\u2014a property of multi-lineage progenitor cells? Cell Mol Life Sci 2004; 61: 2510\u20132522.","journal-title":"Cell Mol Life Sci"},{"key":"BFcddis2017129_CR23","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1242\/jcs.01481","volume":"117","author":"C Huang","year":"2004","unstructured":"Huang C, Jacobson K, Schaller MD . MAP kinases and cell migration. J Cell Sci 2004; 117: 4619\u20134628.","journal-title":"J Cell Sci"},{"key":"BFcddis2017129_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-60761-795-2_7","volume":"661","author":"G Tarcic","year":"2010","unstructured":"Tarcic G, Yarden Y . MAP Kinase activation by receptor tyrosine kinases: in control of cell migration. Methods Mol Biol 2010; 661: 125\u2013135.","journal-title":"Methods Mol Biol"},{"key":"BFcddis2017129_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","volume":"13","author":"S Kamekura","year":"2005","unstructured":"Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005; 13: 632\u2013641.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2017129_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006; 14: 13\u201329.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2017129_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.joca.2009.11.015","volume":"18","author":"RE Franses","year":"2010","unstructured":"Franses RE, McWilliams DF, Mapp PI, Walsh DA . Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthritis Cartilage 2010; 18: 563\u2013571.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2017129_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.lfs.2011.09.005","volume":"89","author":"N Koyama","year":"2011","unstructured":"Koyama N, Okubo Y, Nakao K, Osawa K, Fujimura K, Bessho K . Pluripotency of mesenchymal cells derived from synovial fluid in patients with temporomandibular joint disorder. Life Sci 2011; 89: 741\u2013747.","journal-title":"Life Sci"},{"key":"BFcddis2017129_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jor.22029","volume":"30","author":"I Sekiya","year":"2012","unstructured":"Sekiya I, Ojima M, Suzuki S, Yamaga M, Horie M, Koga H et al. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J Orthop Res 2012; 30: 943\u2013949.","journal-title":"J Orthop Res"},{"key":"BFcddis2017129_CR30","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar2601","volume":"11","author":"DJ Hunter","year":"2009","unstructured":"Hunter DJ, Gerstenfeld L, Bishop G, Davis AD, Mason ZD, Einhorn TA et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009; 11: R11.","journal-title":"Arthritis Res Ther"},{"key":"BFcddis2017129_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X12437353","volume":"4","author":"SR Goldring","year":"2012","unstructured":"Goldring SR . Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis. Ther Adv Musculoskelet Dis 2012; 4: 249\u2013258.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"BFcddis2017129_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature13145","volume":"507","author":"AP Kusumbe","year":"2014","unstructured":"Kusumbe AP, Ramasamy SK, Adams RH . Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 2014; 507: 323\u2013328.","journal-title":"Nature"},{"key":"BFcddis2017129_CR33","first-page":"559","volume":"27","author":"S Portal-Nunez","year":"2012","unstructured":"Portal-Nunez S, Lozano D, Esbrit P . Role of angiogenesis on bone formation. Histol Histopathol 2012; 27: 559\u2013566.","journal-title":"Histol Histopathol"},{"key":"BFcddis2017129_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.22203\/eCM.v015a08","volume":"15","author":"JM Kanczler","year":"2008","unstructured":"Kanczler JM, Oreffo RO . Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cells Mater 2008; 15: 100\u2013114.","journal-title":"Eur Cells Mater"},{"key":"BFcddis2017129_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/scd.2013.0419","volume":"23","author":"SM Nassiri","year":"2014","unstructured":"Nassiri SM, Rahbarghazi R . Interactions of mesenchymal stem cells with endothelial cells. Stem Cells Dev 2014; 23: 319\u2013332.","journal-title":"Stem Cells Dev"},{"key":"BFcddis2017129_CR36","doi-asserted-by":"publisher","first-page":"e30503","DOI":"10.1371\/journal.pone.0030503","volume":"7","author":"H Wang","year":"2012","unstructured":"Wang H, Yin Y, Li W, Zhao X, Yu Y, Zhu J et al. Over-expression of PDGFR-beta promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K\/Akt signaling pathway. PLoS ONE 2012; 7: e30503.","journal-title":"PLoS ONE"},{"key":"BFcddis2017129_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1042\/CS20150622","volume":"130","author":"SY Chien","year":"2016","unstructured":"Chien SY, Huang CY, Tsai CH, Wang SW, Lin YM, Tang CH . Interleukin-1beta induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes. Clin Sci 2016; 130: 667\u2013681.","journal-title":"Clin Sci"},{"key":"BFcddis2017129_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","volume":"14","author":"MC Honorati","year":"2006","unstructured":"Honorati MC, Neri S, Cattini L, Facchini A . Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 2006; 14: 345\u2013352.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2017129_CR39","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/rheumatology\/kes093","volume":"51","author":"K Kayakabe","year":"2012","unstructured":"Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T et al. Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. Rheumatology (Oxford) 2012; 51: 1571\u20131579.","journal-title":"Rheumatology (Oxford)"},{"key":"BFcddis2017129_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jep.2013.10.052","volume":"151","author":"HL Yang","year":"2014","unstructured":"Yang HL, Chang HC, Lin SW, Senthil Kumar KJ, Liao CH, Wang HM et al. Antrodia salmonea inhibits TNF-alpha-induced angiogenesis and atherogenesis in human endothelial cells through the down-regulation of NF-kappaB and up-regulation of Nrf2 signaling pathways. J Ethnopharmacol 2014; 151: 394\u2013406.","journal-title":"J Ethnopharmacol"},{"key":"BFcddis2017129_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1365-2222.2000.00641.x","volume":"30","author":"S Hashimoto","year":"2000","unstructured":"Hashimoto S, Matsumoto K, Gon Y, Maruoka S, Kujime K, Hayashi S et al. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. Clin Exp Allergy 2000; 30: 48\u201355.","journal-title":"Clin Exp Allergy"},{"key":"BFcddis2017129_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jbmr.2828","volume":"31","author":"JL Hamilton","year":"2016","unstructured":"Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ . Targeting VEGF and its receptors for the treatment of osteoarthritis and associated pain. J Bone Miner Res 2016; 31: 911\u2013924.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2017129_CR43","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/ar4044","volume":"14","author":"WP Maksymowych","year":"2012","unstructured":"Maksymowych WP, Russell AS, Chiu P, Yan A, Jones N, Clare T et al. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012; 14: R206.","journal-title":"Arthritis Res Ther"},{"key":"BFcddis2017129_CR44","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/cdd.2016.72","volume":"23","author":"J Xu","year":"2016","unstructured":"Xu J, Wang Y, Li J, Zhang X, Geng Y, Huang Y et al. IL-12p40 impairs mesenchymal stem cell-mediated bone regeneration via CD4+ T cells. Cell Death Differ 2016; 23: 1941\u20131951.","journal-title":"Cell Death Differ"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:42:48Z","timestamp":1671730968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["BFcddis2017129"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.129","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]},"assertion":[{"value":"7 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}